Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has shared an update.
Wai Chun Bio-Technology Ltd. has announced a forthcoming board meeting scheduled for February 28, 2025, in Hong Kong. During this meeting, they plan to discuss and approve the unaudited interim financial results for the six-month period ending December 31, 2024. This announcement may impact the company’s operations and provide insights into its financial performance, with potential implications for stakeholders.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating in the biotechnology sector. It is focused on the production and development of various bio-technological products and solutions.
YTD Price Performance: 10.61%
Average Trading Volume: 58,553
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$12.52M
See more insights into 0660 stock on TipRanks’ Stock Analysis page.